Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-15 5:53 pm | N/A 2033-06-12 | Vaxcyte Inc. | PCVX | Kamarck Michael E. Director | 17,500 | $0 | 20,625 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 4:31 pm | N/A 2033-05-24 | Passage BIO Inc. | PASG | Kamarck Michael E. Director | 21,567 | $0 | 21,567 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 8:32 pm | N/A 2032-07-04 | Passage BIO Inc. | PASG | Kamarck Michael E. Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:32 pm | N/A 2032-05-31 | Vaxcyte Inc. | PCVX | Kamarck Michael E. Director | 21,875 | $0 | 21,875 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:28 pm | N/A 2030-09-17 | Trillium Therapeutics Inc. | TRIL | Kamarck Michael E. Director | 67,000 | $0 | 0 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:11 pm | N/A 2031-10-26 | Vaxcyte Inc. | PCVX | Kamarck Michael E. Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-10-29 6:09 pm | N/A N/A | Vaxcyte Inc. | PCVX | Kamarck Michael E. Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-01-04 8:11 pm | N/A 2030-09-17 | Trillium Therapeutics Inc. | TRIL | Kamarck Michael E. Director | 0 | $0 | 67,000 (Direct) | View |
Ownership | 2019-10-10 7:08 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Kamarck Michael E. Chief Technology Officer | 0 | $0 | 444,443 (Direct) | View |